Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Outcomes of patients with or without DNA repair pathway alterations: the MD Anderson IMPACT2 study.
Journal: NPJ precision oncology
Published: December 10, 2025
Author Correction: PPP2R1A mutations portend improved survival after cancer immunotherapy.
Journal: Nature
Published: September 05, 2025
Phase I Trial of TTI-101, a First-in-Class Oral Inhibitor of STAT3, in Patients with Advanced Solid Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 13, 2024
Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma.
Journal: Journal for immunotherapy of cancer
Published: January 09, 2024
The Scottish Medical Imaging Archive: A Unique Resource for Imaging-related Research.
Journal: Radiology. Artificial intelligence
Published: January 02, 2024
Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum-resistant ovarian cancer.
Journal: Cancer
Published: August 03, 2023
Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-in-Human Clinical Trial in Patients with Advanced Metastatic Cancer.
Journal: Cancer immunology research
Published: September 01, 2022
Challenges and opportunities associated with the MD Anderson IMPACT2 randomized study in precision oncology.
Journal: NPJ precision oncology
Published: May 24, 2022
Ipilimumab, Pembrolizumab, or Nivolumab in Combination with BBI608 in Patients with Advanced Cancers Treated at MD Anderson Cancer Center.
Journal: Cancers
Published: January 29, 2022
Interactive Multimedia Reporting Technical Considerations: HIMSS-SIIM Collaborative White Paper.
Journal: Journal of digital imaging
Published: December 30, 2021
Last Updated: 09/26/2026